Psoriasis Clinical Trial

Clinical Trial Finder Psoriasis Trials

Single Ascending Dose Study of PRX003 in Healthy Subjects

See Locations Near You

Summary

This single ascending dose study is to determine safety, tolerability, pharmacokinetics and immunogenicity of PRX003 in approximately 40 healthy subjects.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Healthy subjects
Body mass index (BMI) between 18-32 kg/m2 with a minimum weight of 45 kg
Female subjects must be surgically sterile or post-menopausal or if of child-bearing potential must use contraception
Male subjects and their partners of childbearing potential must use contraception

Exclusion Criteria:

Positive test for drug of abuse
Past or current history of alcohol abuse
Positive for TB, hepatitis B, hepatitis C or HIV infection

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

40

Study ID:

NCT02458677

Recruitment Status:

Completed

Sponsor:

Prothena Biosciences Limited

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Worldwide Clinical Trials Early Phase Services
San Antonio Texas, , United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

40

Study ID:

NCT02458677

Recruitment Status:

Completed

Sponsor:


Prothena Biosciences Limited

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider